Publications

Life Saving Drugs Program – Pompe disease – Guidelines

These guidelines contain the general, initial and ongoing eligibility requirements to access treatment for infantile-onset, juvenile late-onset or adult late-onset Pompe disease under the Life Saving Drugs Program.

Downloads

Life Saving Drugs Program – Pompe disease – Guidelines

We aim to provide documents in an accessible format. If you're having problems using a document with your accessibility tools, please contact us for help.

Publication date:
Last updated:
Publication type:
Guideline
Audience:
Health sector
Language:
English
Description:

These guidelines include:

  • General information about the Life Saving Drugs Program (LSDP)
  • Treatment of Pompe disease through the LSDP
  • Drugs currently available for the treatment of Pompe disease through the LSDP
  • Dosage
  • General, initial and ongoing eligibility requirements
  • LSDP funding conditions
  • Exclusion criteria.
Part of a collection:
Life Saving Drugs Program resources – Pompe disease
Tags: 

Help us improve health.gov.au

If you would like a response please use the enquiries form instead.